TickerFacts.

60 Degrees Pharmaceuticals, Inc. (SXTP): Long-Term Debt

Annual figures by period end, from SEC filings.

$150.0K
As of 2025-12-31
$150.0K
As of 2026-06-30
2023-12-31: $150.0K2024-12-31: $150.0K2025-12-31: $150.0K$150.0K
2023-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$150.0K0.0%2026-03-30, Balance as of period end
2024-12-31$150.0K0.0%2025-03-27, Balance as of period end
2023-12-31$150.0Kn/a2024-04-01, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$150.0K0.0%
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31$807.2K+27.8%
Northwest Biotherapeutics Inc (NWBO)2025-12-31$60.04M-4.2%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$109.59M+6.9%
Rani Therapeutics Holdings, Inc. (RANI)2024-12-31$25.00M-16.7%
Yarrow Bioscience, Inc. (YARW)2025-12-31$0n/a
Bio Essence Corp (BIOE)2025-12-31$57.5K+1.8%
Scienture Holdings, Inc. (SCNX)2024-12-31$2.90Mn/a
Clene Inc. (CLNN)2025-12-31$17.79Mn/a

Compare SXTP, SXTC, NWBO, BTAIQ side by side · Screen every company in Pharmaceutical Preparations ↗